KRIYA-825

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameKRIYA-825
Drug Alias NameKRIYA-825VV-14295
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV2 vector
Mechanisms of ActionComplement C3 inhibitorsComplement C5 inhibitors
TargetsComplement C3Complement C5
Therapy Area/IndicationsGeographic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNew Zealand +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKriya Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKriya Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGeographic Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A